Egetis Therapeutics AB
P0F
Company Profile
Business description
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.
Contact
Grev Turegatan 11 C
Stockholm114 46
SWET: +46 86797210
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
40
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.30 | 22.50 | 0.26% |
| CAC 40 | 7,773.93 | 5.79 | -0.07% |
| DAX 40 | 24,051.20 | 117.97 | 0.49% |
| Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
| FTSE 100 | 8,745.93 | 29.48 | 0.34% |
| HKSE | 23,289.77 | 283.61 | -1.20% |
| NASDAQ | 19,175.87 | 74.93 | 0.39% |
| Nikkei 225 | 37,965.10 | 467.88 | -1.22% |
| NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
| S&P 500 | 5,912.17 | 23.62 | 0.40% |
| S&P/ASX 200 | 8,434.70 | 24.90 | 0.30% |
| SSE Composite Index | 3,347.49 | 15.96 | -0.47% |